302 related articles for article (PubMed ID: 19906170)
1. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma.
Sotiriou E; Apalla Z; Ioannides D
Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170
[No Abstract] [Full Text] [Related]
2. Epidermoid cysts mimicking recurrence of superficial basal cell carcinoma following photodynamic therapy.
Ghaffar SA; Clements SE; Lear JT
Clin Exp Dermatol; 2007 Mar; 32(2):223-4. PubMed ID: 17137478
[No Abstract] [Full Text] [Related]
3. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
4. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome.
Chapas AM; Gilchrest BA
J Drugs Dermatol; 2006 Feb; 5(2 Suppl):3-5. PubMed ID: 16485873
[TBL] [Abstract][Full Text] [Related]
5. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light.
Fink-Puches R; Wolf P; Kerl H
Arch Dermatol; 1997 Dec; 133(12):1494-5. PubMed ID: 9420532
[No Abstract] [Full Text] [Related]
7. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
[TBL] [Abstract][Full Text] [Related]
9. Rapid progression of a basal cell carcinoma after photodynamic therapy.
Karen JK; Hale EK
Dermatol Surg; 2010 Aug; 36(8):1328-31. PubMed ID: 20584044
[No Abstract] [Full Text] [Related]
10. Fibroepithelioma of Pinkus: poor response to topical photodynamic therapy.
Park MY; Kim YC
Eur J Dermatol; 2010; 20(1):133-4. PubMed ID: 19919909
[No Abstract] [Full Text] [Related]
11. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
12. A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes.
Sebaratnam DF; Venugopal SS; Murrell DF
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):117-8. PubMed ID: 20456551
[No Abstract] [Full Text] [Related]
13. Photodynamic treatment of skin malignancies with aminolevulinic acid. Emphasis on anatomical observations and in vivo erythema visual assessment.
Tosca AD; Balas CJ; Stefanidou MP; Katsantonis JC; Georgiou SK; Tzardi MN
Dermatol Surg; 1996 Nov; 22(11):929-34. PubMed ID: 9063508
[TBL] [Abstract][Full Text] [Related]
14. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
15. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy.
Naidenov N; Dencheva R; Tsankov N
Acta Dermatovenerol Croat; 2004; 12(3):157-61. PubMed ID: 15369639
[TBL] [Abstract][Full Text] [Related]
16. [Photodynamic therapy of nasal basal cell carcinoma].
Haddad R; Cohen M; Kaplan O; Greenberg R; Kashtan H
Harefuah; 2001 Jan; 140(1):25-7, 86. PubMed ID: 11242893
[TBL] [Abstract][Full Text] [Related]
17. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
Szeimies RM
Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
[TBL] [Abstract][Full Text] [Related]
18. The use of photodynamic therapy in dermatology: results of a consensus conference.
Nestor MS; Gold MH; Kauvar AN; Taub AF; Geronemus RG; Ritvo EC; Goldman MP; Gilbert DJ; Richey DF; Alster TS; Anderson RR; Bank DE; Carruthers A; Carruthers J; Goldberg DJ; Hanke CW; Lowe NJ; Pariser DM; Rigel DS; Robins P; Spencer JM; Zelickson BD
J Drugs Dermatol; 2006 Feb; 5(2):140-54. PubMed ID: 16485882
[TBL] [Abstract][Full Text] [Related]
19. Sequential effects of photodynamic treatment of basal cell carcinoma.
Prignano F; Lotti T; Spallanzani A; Berti S; de Giorgi V; Moretti S
J Cutan Pathol; 2009 Apr; 36(4):409-16. PubMed ID: 19278425
[TBL] [Abstract][Full Text] [Related]
20. Topical photodynamic therapy in clinical dermatology.
Kormeili T; Yamauchi PS; Lowe NJ
Br J Dermatol; 2004 Jun; 150(6):1061-9. PubMed ID: 15214890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
